FDA Drug Application (202971) for ABILIFY MAINTENA KIT by OTSUKA PHARM CO LTD

Back to FDA Applications sponsored by OTSUKA PHARM CO LTD

Application Number202971
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
Dosage300MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY MAINTENA KIT
Active IngredientARIPIPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient ARIPIPRAZOLE3


Back to FDA Applications sponsored by OTSUKA PHARM CO LTD